Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)

China · Delayed Price · Currency is CNY

28.68

+0.13 (0.46%)

Jul 31, 2026, 3:00 PM CST

SHA:688062 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	745.32	662.52	199.78	127.84	27.73	16.23
Revenue Growth	321.05%	231.62%	56.28%	361.03%	70.88%	206.03%
Gross Profit	649.14	586.79	165.3	120.53	25.72	11
Operating Income	-827.04	-891.85	-1,027	-1,087	-1,002	-801.44
Net Income	-919.55	-969.33	-1,044	-1,053	-955.23	-769.59
Earnings Per Share	-2.31	-2.43	-2.61	-2.64	-2.44	-2.57
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Mainland China	582.13
Other Regions	80.38
Total	662.52

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,489	1,528	1,232	1,701	2,551	96.54
Total Debt	3,265	2,972	2,216	1,293	774.45	334.58
Net Cash (Debt)	-1,776	-1,444	-983.91	408.4	1,777	-238.03
Net Cash Growth	-	-	-	-77.01%	-	-
Net Cash Per Share	-4.46	-3.62	-2.46	1.02	4.54	-0.79

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-307.77	-290.22	-956.44	-782.73	-719.17	-422.4
Capital Expenditures	-167.18	-157.71	-330.07	-499.91	-544.96	-217.51
Free Cash Flow	-474.95	-447.93	-1,287	-1,283	-1,264	-639.91
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	87.09%	88.57%	82.74%	94.29%	92.75%	67.81%
Operating Margin	-110.96%	-134.62%	-514.17%	-850.65%	-3615.06%	-4939.16%
Pretax Margin	-121.31%	-144.36%	-524.31%	-825.50%	-3455.42%	-4762.04%
Profit Margin	-123.38%	-146.31%	-522.53%	-824.05%	-3445.00%	-4742.85%
FCF Margin	-63.73%	-67.61%	-643.96%	-1003.35%	-4559.01%	-3943.69%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	16.48	23.19	40.40	102.19	208.24	-